cas 34381-71-0|| where to buy [(2S)-1-methylpyrrolidin-2-yl]methanol

Nombre del producto:[(2S)-1-methylpyrrolidin-2-yl]methanol

IUPAC Name:[(2S)-1-methylpyrrolidin-2-yl]methanol

Unidad de embalaje	Stock disponible	Precio($)
CM328420-100g	in stock	ŵȡƎ
CM328420-500g	in stock	ǜǶư

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 34381-71-0 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :34381-71-0; Fórmula molecular:C6H13NO; Punto de fusión:-; Código de sonrisas:OC[C@H]1N(C)CCC1; Densidad:

: Número de catálogo:CM328420; Peso molecular:115.18; Punto de ebullición:; Nº Mdl:MFCD00011727; Almacenamiento:

: Pyrrolidines; Pyrrolidine, also known as tetrahydropyrrole, is a saturated five-membered heterocyclic ring, which is miscible with water. Pyrrolidine exists in many alkaloids and drug molecules, such as kappa opioids, antagonists of dopamine D4 receptors, and HIV reverse transcriptase inhibitors.

: Adagrasib; Jan. 10, 2024, EC approves KRAZATI (adagrasib) as a targeted treatment option for patients with advanced non-small cell lung cancer (NSCLC) with a KRAS G12C mutation.
Adagrasib is an orally available, potent, irreversible, small molecule inhibitor of KRAS G12C mutant isoform for the treatment of solid tumours harbouring KRAS G12C oncogenic driver mutation. Adagrasib covalently binds to the mutant cysteine in KRAS G12C and locks the mutant KRAS protein in its inactive state, thereby preventing downstream signalling without affecting wild-type KRAS protein.